Inhibitor Therapeutics (INTI) Payables (2012 - 2026)
Inhibitor Therapeutics (INTI) recorded Payables of $139,052 in Q2 2026, up 30.9% from $106,249 a year earlier but down 56.5% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Payables (2012 - 2026) Analysis & Trends
At the end of FY2025, Inhibitor Therapeutics reported Payables of $51,521, up 224.1% from FY2024.
- Annual Payables has a five-year compound annual growth rate of -33.6% (FY2020 to FY2025).
- Across earlier years, Payables came in at $15,896 in FY2024 (-52.9%), $33,731 in FY2023 (-93.9%), $556,161 in FY2022 (-9.1%) and $611,665 in FY2021 (+52.8%).
- Quarterly Payables has ranged from $1,706 in Q3 2024 to $987,877 in Q3 2022 over the past five years.
- On a year-over-year basis, Payables has increased for three consecutive quarters, with growth averaging 181.9% over the last seven quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 771.4% in Q1 2026, against a decline of 99.3% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $319,803 (Q1 2026), $51,521 (Q4 2025) and $19,646 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 139,052.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 139,052.00 |
| Mar 31, 2026 | 319,803.00 |
| Dec 31, 2025 | 51,521.00 |
| Sep 30, 2025 | 19,646.00 |
| Jun 30, 2025 | 106,249.00 |
| Mar 31, 2025 | 36,702.00 |
| Dec 31, 2024 | 15,896.00 |
| Sep 30, 2024 | 1,706.00 |
| Jun 30, 2024 | 18,803.00 |
| Mar 31, 2024 | 111,916.00 |
| Dec 31, 2023 | 33,731.00 |
| Sep 30, 2023 | 93,147.00 |
| Jun 30, 2023 | 11,750.00 |
| Mar 31, 2023 | 5,007.00 |
| Dec 31, 2022 | 556,161.00 |
| Sep 30, 2022 | 987,877.00 |
| Jun 30, 2022 | 842,880.00 |
| Mar 31, 2022 | 752,839.00 |
| Dec 31, 2021 | 611,665.00 |
| Sep 30, 2021 | 355,231.00 |
API Access
Inhibitor Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();